SCHEDULE 13G/A: Atreides Management Discloses 1.2% Passive Stake in Astera Labs

Atreides Management, LP, along with its affiliates, has filed an amended Schedule 13G disclosing a passive beneficial ownership of 1.2% in Astera Labs, Inc.

Summary

• Atreides Management, LP, Atreides Management, LLC, and Gavin Baker (collectively, the 'Reporting Persons') have filed an Amendment No. 1 to Schedule 13G.
• The filing discloses their beneficial ownership in Astera Labs, Inc. Common Stock, par value $0.0001 per share.
• As of December 31, 2024, the Reporting Persons collectively beneficially own 1,836,650 shares of Astera Labs Common Stock.
• This ownership represents 1.2% of Astera Labs' outstanding Common Stock.
• The percentage is calculated based on 158,610,853 shares reported outstanding by Astera Labs as of October 31, 2024, in its Form 10-Q.
• The Reporting Persons have shared voting power and shared dispositive power over all 1,836,650 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of ownership and does not contain information that would indicate a positive or negative sentiment towards the issuer or the reporting persons' investment strategy.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of passive ownership by an investment manager in a publicly traded company. It does not provide specific insights into broader industry trends or competitive dynamics beyond the fact that Astera Labs operates in a sector attracting institutional investment.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant passive ownership stakes in Astera Labs, Inc.

Key Dates

Keywords

Astera Labs, Atreides Management, Gavin Baker, Schedule 13G, Ownership Disclosure, Common Stock, Beneficial Ownership, Passive Investment, SEC Filing